Whitecap Venture Partners

Felix Health Inc. is an online prescription platform based in Toronto, Canada, that provides medications for various health concerns, including erectile dysfunction, hair loss, acne, and birth control. Founded in 2019, the company aims to modernize healthcare in Canada by offering a seamless and straightforward experience for users seeking effective treatments for their specific needs. Felix Health focuses on making healthcare more accessible and convenient for individuals navigating personal health issues.

Ukko Agro develops an agriculture ecosystem that helps optimize pesticide usage to minimize crop losses. It offers technology tools that facilitate on-farm decision making with minimal time investment from the growers. The company is driven to optimize pesticide use for better crop yield, by integrating technologies to track, analyze, and quantify sustainability gained. Its product features realtime on-farm monitoring, predicts disease or pest attacks, prescribe pesticide spray, integrates with external on-farm equipment and technologies, reduces crop losses, and optimizes crop inputs. Ukko Agro was founded in 2017 and is headquartered in Toronto, Ontario.

Qvella Corporation is a molecular diagnostics company based in Toronto, Canada, focused on revolutionizing clinical microbiology through innovative technologies. Founded in 2009 by a group of scientists and engineers, the company aims to significantly reduce the time required to obtain results for microbiological tests. Qvella's flagship technology, known as Field Activated Sample Treatment (FAST™), employs a unique electrical lysing and sample treatment method called e-lysis™. This approach allows for the rapid and direct detection of infectious agents from unenriched biological samples, such as whole blood, without the need for extensive sample processing. By delivering actionable results in clinically relevant time frames, Qvella's technology seeks to enhance patient outcomes and improve the overall practice of medicine.

Felix Health Inc. is an online prescription platform based in Toronto, Canada, that provides medications for various health concerns, including erectile dysfunction, hair loss, acne, and birth control. Founded in 2019, the company aims to modernize healthcare in Canada by offering a seamless and straightforward experience for users seeking effective treatments for their specific needs. Felix Health focuses on making healthcare more accessible and convenient for individuals navigating personal health issues.

Qvella Corporation is a molecular diagnostics company based in Toronto, Canada, focused on revolutionizing clinical microbiology through innovative technologies. Founded in 2009 by a group of scientists and engineers, the company aims to significantly reduce the time required to obtain results for microbiological tests. Qvella's flagship technology, known as Field Activated Sample Treatment (FAST™), employs a unique electrical lysing and sample treatment method called e-lysis™. This approach allows for the rapid and direct detection of infectious agents from unenriched biological samples, such as whole blood, without the need for extensive sample processing. By delivering actionable results in clinically relevant time frames, Qvella's technology seeks to enhance patient outcomes and improve the overall practice of medicine.

Qvella Corporation is a molecular diagnostics company based in Toronto, Canada, focused on revolutionizing clinical microbiology through innovative technologies. Founded in 2009 by a group of scientists and engineers, the company aims to significantly reduce the time required to obtain results for microbiological tests. Qvella's flagship technology, known as Field Activated Sample Treatment (FAST™), employs a unique electrical lysing and sample treatment method called e-lysis™. This approach allows for the rapid and direct detection of infectious agents from unenriched biological samples, such as whole blood, without the need for extensive sample processing. By delivering actionable results in clinically relevant time frames, Qvella's technology seeks to enhance patient outcomes and improve the overall practice of medicine.

Qvella Corporation is a molecular diagnostics company based in Toronto, Canada, focused on revolutionizing clinical microbiology through innovative technologies. Founded in 2009 by a group of scientists and engineers, the company aims to significantly reduce the time required to obtain results for microbiological tests. Qvella's flagship technology, known as Field Activated Sample Treatment (FAST™), employs a unique electrical lysing and sample treatment method called e-lysis™. This approach allows for the rapid and direct detection of infectious agents from unenriched biological samples, such as whole blood, without the need for extensive sample processing. By delivering actionable results in clinically relevant time frames, Qvella's technology seeks to enhance patient outcomes and improve the overall practice of medicine.